Sujets)
Adolescent , Carbonate de calcium , Corps étrangers/psychologie , Humains , Intestins , MâleRésumé
Twenty one patients age ranging from 26-70 years, with biopsy proven recurrent/advanced carcinoma of the cervix were treated with bleomycin, cisplatinum and ifosfamide infusion therapy. 88% patients reported subjective improvement. The objective response rate was 66.6% (Complete 38% and partial 28.5%). Side effects were mainly nausea, vomiting, and alopecia. Treatment related fever was common. Hematuria and reversible encephalopathy with ifosfamide were seen in three and two patients respectively. These results indicate that BIP infusion chemotherapy is an active and safe combination for treatment of advanced/recurrent cervical cancer.
Sujets)
Adulte , Sujet âgé , Protocoles de polychimiothérapie antinéoplasique/effets indésirables , Bléomycine/administration et posologie , Carcinome épidermoïde/traitement médicamenteux , Cisplatine/administration et posologie , Femelle , Humains , Ifosfamide/administration et posologie , Adulte d'âge moyen , Récidive tumorale locale/traitement médicamenteux , Taux de survie , Résultat thérapeutique , Tumeurs du col de l'utérus/traitement médicamenteuxRésumé
Two patients with primary Hodgkin's disease of the small intestine are reported because of rarity of this condition. Both patients presented with primary intestinal symptoms and were diagnosed after surgical resection. The modalities of treatment and favorable long term survival are presented.